Ticker

No recent analyst price targets found for AACAY.

Latest News for AACAY

Goodnites® Launches "Language of Bedwetting," the First Complete Language Designed to Help Autistic Children Express Needs, Wants and Feelings Around Bedwetting

Developed with a licensed speech-language pathologist and the Autism Society of America, this freecommunication tool helps fill a gap in Augmentative and Alternative Communication (AAC) vocabulary,giving non-speaking or minimally speaking individuals the vocabulary to express themselves around apotential nightly experience. CHICAGO, April 2, 2026 /PRNewswire/ -- Today on World Autism Awareness Day 2026, Goodnites®,…

PRNewsWire • Apr 2, 2026
Are Investors Undervaluing AAC Technologies (AACAY) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • Jan 22, 2026
France Expands National AAC Access for Agenus' Botensilimab + Balstilimab for Ovarian Cancer and Soft-Tissue Sarcomas

LEXINGTON, Mass.--(BUSINESS WIRE)---- $AGEN #BAL--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that France's National Agency for Medicines and Health Products Safety (ANSM) has approved an updated national treatment protocol for botensilimab (BOT) plus balstilimab (BAL) under France's Autorisation d'Accès Compassionnel (AAC) framework. The updated protocol expands France's…

Business Wire • Jan 12, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for AACAY.

No Senate trades found for AACAY.

No House trades found for AACAY.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top